Surakit Nathisuwan, Robert L Talbert. Pharmacotherapy 2002
Times Cited: 35
Times Cited: 35
J A Robl, C Q Sun, J Stevenson, D E Ryono, L M Simpkins, M P Cimarusti, T Dejneka, W A Slusarchyk, S Chao, L Stratton, R N Misra, M S Bednarz, M M Asaad, H S Cheung, B E Abboa-Offei, P L Smith, P D Mathers, M Fox, T R Schaeffer, A A Seymour, N C Trippodo. J Med Chem 1997
Times Cited: 135
Times Cited: 135
List of shared articles
Times cited
Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design.
Gyles E Cozier, Lauren B Arendse, Sylva L Schwager, Edward D Sturrock, K Ravi Acharya. J Med Chem 2018
Gyles E Cozier, Lauren B Arendse, Sylva L Schwager, Edward D Sturrock, K Ravi Acharya. J Med Chem 2018
Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme.
Urvashi Sharma, Gyles E Cozier, Edward D Sturrock, K Ravi Acharya. J Med Chem 2020
Urvashi Sharma, Gyles E Cozier, Edward D Sturrock, K Ravi Acharya. J Med Chem 2020
Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves.
Roland Veelken, Roland E Schmieder. J Hypertens 2002
Roland Veelken, Roland E Schmieder. J Hypertens 2002